Lung Cancers Active Not Recruiting Phase 2 Trials for Erlotinib (DB00530)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

DBCOND0072929 (Lung Cancers)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT01248247BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung CancerTreatment
NCT00436332S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar CarcinomaTreatment